KALA BIO CEO Lazar sells Series AAA preferred rights; consultant hired for strategic alternatives

KALA BIO, Inc.

Annual meeting set for Jan 30, 2026; stockholder proposals and director nominations due Dec 27, 2025.
David Lazar sold his rights to purchase Series AAA Preferred Shares (up to $4.2M) to unaffiliated AK Holdings Group Inc.
Company retains consultant, a principal of AK Holdings, to advise on identifying and consummating a strategic alternative transaction.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.